Chronic exposure to melatonin receptor agonists does not alter their effects on suprachiasmatic nucleus neurons

Author： Ying S.-W.   Rusak B.   Mocaer E.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.342, Iss.1, 1998-01, pp. : 29-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular effects of melatonin receptor agonists

By Paulis Ludovit   Simko Fedor   Laudon Moshe  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 11, 2012-11 ,pp. : 1661-1678

Informa Healthcare

Access to resources Recommend Favorite

Investigational melatonin receptor agonists

By Hardeland Rüdiger  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 6, 2010-06 ,pp. : 747-764

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of melatonin receptor agonists and antagonists

By Dubocovich M.L.  

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 153-173

Informa Healthcare

Access to resources Recommend Favorite

The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens

By Mirza N.R.   Qi P.   Stolerman I.P.   Zetterstrom T.S.C.  

European Journal of Pharmacology, Vol. 295, Iss. 2, 1996-01 ,pp. : 207-210

Elsevier

Access to resources Recommend Favorite

Effects of 5-HT 1A and 5-HT 4 receptor agonists on slow synaptic potentials in enteric neurons

By Pan H.   Galligan J.J.  

European Journal of Pharmacology, Vol. 278, Iss. 1, 1995-05 ,pp. : 67-74

Elsevier

Access to resources Recommend Favorite